Page 47 - Read Online

Page 16 of 17 Marasco et al. Hepatoma Res 2020;6:32 I http://dx.doi.org/10.20517/2394-5079.2019.54

dysfunction and infection after major liver resection. Gut 2005;54:289-96.
114. Chuang YH, Ou HY, Lazo MZ, Chen CL, Chen MH, et al. Predicting post-hepatectomy liver failure by combined volumetric, functional
MR image and laboratory analysis. Liver Int 2018;38:868-74.
115. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, et al. Portal vein embolization before major hepatectomy and its effects on
regeneration, resectability and outcome. Br J Surg 2007;94:1386-94.
116. Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg 2012;29:6-
17.
117. Kauffmann R, Fong Y. Post-hepatectomy liver failure. Hepatobiliary Surg Nutr 2014;3:238-46.
118. Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, et al. Underlying steatohepatitis, but not simple hepatic steatosis, increases
morbidity after liver resection: a case-control study. Hepatology 2012;56:2221-30.
119. Kaido T, Hamaguchi Y, Uemoto S. Significance of preoperative sarcopenia to liver surgery. HepatoBiliary Surg Nutr 2019;8:59-62.
120. Valero V, Amini N, Spolverato G, Weiss MJ, Hirose K, et al. Sarcopenia adversely impacts postoperative complications following
resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 2015;19:272-81.
121. Peng PD, Van Vledder MG, Tsai S, De Jong MC, Makary M, et al. Sarcopenia negatively impacts short-term outcomes in patients
undergoing hepatic resection for colorectal liver metastasis. HPB 2011;13:439-46.
122. Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol 2014;20:7286-
97.
123. Maharshi S, Sharma BC, Srivastava S. Malnutrition in cirrhosis increases morbidity and mortality. J Gastroenterol Hepatol 2015;30:1507-
13.
124. Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, et al. Assessment of malnutrition, sarcopenia and frailty in patients with
cirrhosis: which tools should we use in clinical practice? Nutrients 2020;12.
125. Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: Sarcopenia in cirrhosis - Aetiology, implications and potential therapeutic
interventions. Aliment Pharmacol Ther 2016;43:765-77.
126. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for
Sarcopenia. J Am Med Dir Assoc 2014;15:95-101.
127. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, et al. Sarcopenia as a predictor of prognosis in patients following
hepatectomy for hepatocellular carcinoma. Br J Surg 2013;100:1523-30.
128. Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, et al. Sarcopenia impacts on short- and long-term results of hepatectomy for
hepatocellular carcinoma. Ann Surg 2015;261:1173-83.
129. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, et al. Preoperative visceral adiposity and muscularity predict poor outcomes
after hepatectomy for hepatocellular carcinoma. Liver Cancer 2019;8:92-109.
130. Dello SAWG, Lodewick TM, Van Dam RM, Reisinger KW, Van Den Broek MAJ, et al. Sarcopenia negatively affects preoperative total
functional liver volume in patients undergoing liver resection. HPB 2013;15:165-9.
131. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin
Clin Nutr Metab Care 2008;11:693-700.
132. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Fujimoto Y, et al. Muscle steatosis is an independent predictor of postoperative
complications in patients with hepatocellular carcinoma. World J Surg 2016;40:1959-68.
133. Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, et al. Bone mineral density predicts posttransplant survival among hepatocellular
carcinoma liver transplant recipients. Liver Transplant 2016;22:1092-8.
134. Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, et al. Bone mineral density as a risk factor for patients undergoing surgery for
hepatocellular carcinoma. World J Surg 2019;43:920-8.
135. Shen YN, Zheng ML, Guo CX, Bai XL, Pan Y, et al. The role of imaging in prediction of post-hepatectomy liver failure. Clin Imaging
2018;52:137-45.
136. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions
with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003;226:71-8.
137. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence:
detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998;170:397-402.
138. Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects
in normal and cirrhotic livers. Eur J Radiol 2011;80:e311-6.
139. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, et al. Preclinical evaluation of Gd-EOB-DTPA as a
contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.
140. Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, et al. Qualitative and quantitative evaluation of hepatocellular
carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol. 200;193:1053-60.
141. Kukuk GM, Schaefer SG, Fimmers R, Hadizadeh DR, Ezziddin S, et al. Hepatobiliary magnetic resonance imaging in patients with liver
disease: correlation of liver enhancement with biochemical liver function tests. Eur Radiol 2014;24:2482-90.
142. Watanabe H, Kanematsu M, Goshima S, Kondo H, Onozuka M, et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-
enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology 2011;259:142-50.
143. Wibmer A, Prusa AM, Nolz R, Gruenberger T, Schindl M, et al. Liver failure after major liver resection: risk assessment by using
preoperative gadoxetic acid-enhanced 3-T MR imaging. Radiology 2013;269:777-86.
144. Jin YJ, Lee SH, Cho SG, Kim JH, Lee JW, et al. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic